Join the Hemodialysis group to help and get support from people like you.
Hemodialysis News
Standardization Needed for Dialysis Initiation in Pregnancy
WEDNESDAY, July 23, 2025 – The initiation of dialysis in women with chronic kidney disease during pregnancy varies by clinical practice, signaling a need for standardized care in this population,...
Public Health Response Data Show Success of Standard Infection Control Measures for Dialysis
MONDAY, July 14, 2025 – Adherence to standard dialysis infection prevention and control (IPC) measures enabled safe provision of dialysis to patients with Candida auris colonization or infection,...
COVID Vaccine Protects Against Kidney Damage During Infection
MONDAY, June 16, 2025 — Kidney damage is common during a severe case of COVID-19, but vaccination appears to protect people against this life-threatening side effect, a new study says. Unvaccinated C...
Standard-Criteria Kidney Transplant Offers Clear Survival Benefit Over Continued Dialysis
TUESDAY, June 10, 2025 – Transplantation with standard-criteria kidney offers a clear survival benefit, but this decreases with age and for those with a history of cardiovascular disease (CVD),...
Higher Temperatures Tied to Greater Risk for Mortality in People Undergoing Dialysis
WEDNESDAY, April 23, 2025 – Moderately elevated ambient temperature is associated with increased mortality in patients undergoing dialysis, according to a study published in the February issue of...
Study IDs Factors Linked to Risk for Transfer From Peritoneal Dialysis to Hemodialysis
WEDNESDAY, Feb. 26, 2025 – Nurse assistance is associated with a lower risk for transfer from peritoneal dialysis (PD) to hemodialysis (HD) for infection in the first 18 months and for adequacy...
Denosumab Increases Cardiovascular Risk in Dialysis-Dependent Patients
TUESDAY, Jan. 7, 2025 – For dialysis-dependent patients treated for osteoporosis, denosumab is associated with a greater preventive effect on fractures but an increased risk for major adverse...
Pain Coping Skills Training Beneficial During Maintenance Hemodialysis
MONDAY, Dec. 30, 2024 – Pain coping skills training (PSCT) is beneficial for patients undergoing maintenance hemodialysis and experiencing chronic pain, according to a study published online Dec. 30...
Women, Men on Kidney Dialysis Face Different Heart Risks
FRIDAY, Nov. 8, 2024 – Women have a higher risk of heart failure and stroke than men while undergoing dialysis for kidney failure, a new study shows. However, women also have a lower overall risk of...
Machine Learning Can Predict Intradialytic Hypotension During Hemodialysis
WEDNESDAY, Nov. 6, 2024 – Clinical data and machine learning can help to predict intradialytic hypotension (IDH) for patients undergoing hemodialysis, according to a study published online Sept. 14...
Varying Dialysate Calcium Dosage Not Tied to Differences in All-Cause, Cardiovascular Mortality
FRIDAY, Oct. 18, 2024 – There are no significant differences in all-cause or cardiovascular mortality with the prescription of dialysate calcium 1.50 versus 1.25 mmol/L for patients undergoing...
Modest Gains in Life Expectancy Seen for Dialysis in Older Adults With eGFR
MONDAY, Aug. 19, 2024 – For older adults, starting dialysis when the estimated glomerular filtration rate (eGFR) falls below 12 mL/min/1.73 m2 results in modest gains in life expectancy, according...
Is Dialysis Always Warranted for End-Stage Kidney Failure?
TUESDAY, Aug. 20, 2024 – Some seniors with end-stage kidney failure who are too sick for a transplant should probably skip dialysis because the health trade-offs aren't worth it, a new study says....
FDA Approves Amgen's Parsabiv (etelcalcetide) for Secondary Hyperparathyroidism in Adult Patients on Hemodialysis
THOUSAND OAKS, Calif., Feb. 7, 2017 /PRNewswire/ – Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Parsabiv (etelcalcetide) for the treatment of...
FDA Medwatch Alert: Dialysate Concentrates Used in Hemodialysis: Safety Communication - Alkali Dosing Errors
[UPDATED 06/27/2012] FDA issued a Class I Recall notice for Fresenius Medical Care North America Naturalyte Liquid Acid Concentrate and Naturalyte GranuFlo (powder) Acid Concentrate. Inappropriate ...